Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been
Former Elscint executive Robert Sohval has joined SmartLight,an Israeli technology firm that has developed a computer-controlledlight box designed to automatically mask glare from light usedto illuminate x-ray films (SCAN 1/31/96). Sohval has been namedpresident and CEO of SmartLight's U.S. subsidiary, based in Hackensack,NJ.
Sohval left Elscint in 1994 for TransScan Medical, a development-stagecompany working on breast-imaging technology using electricalimpedance rather than x-rays. At SmartLight, one of Sohval's firstduties is to build a sales and marketing organization to sellthe company's SmartLight 2000 Plus and SmartLight 4000 Plus systems.
SmartLight has placed the systems at beta sites and expectsto begin commercial shipments in the fourth quarter of this year,Sohval said.
What a New Meta-Analysis Reveals About PET/CT Radiotracers for csPCa
February 6th 2025The PET/CT agent 18F-PSMA-1007 offered the highest surface under the cumulative ranking curve (SUCRA) out of nine radiotracers at the patient and lesion level for detecting clinically significant prostate cancer (csPCa), according to a meta-analysis.
New CT Angiography Study Shows Impact of COVID-19 on Coronary Inflammation and Plaque
February 5th 2025Prior COVID-19 infection was associated with a 28 percent higher progression of total percent atheroma volume (PAV) annually and over a 5 percent higher incidence of high-risk plaque in patients with coronary artery lesions, according to CCTA findings from a new study.